Huaquejing Medical

Established in 2019, Huaquejing Medical develops intelligent rehabilitation robots and broad smart rehabilitation solutions from its Shenzhen headquarters. The company has achieved National High-Tech Enterprise certification and holds over 70 intellectual property rights including domestic and international patents. Multiple products in its portfolio have received NMPA Class II medical device registration certificates.

Company Overview

Huaquejing Medical was founded by a team with over 15 years of combined experience in rehabilitation medicine, medical robotics, artificial intelligence, and virtual reality. CEO Dr. Wu Jianhuang serves as a researcher and doctoral supervisor at the Chinese Academy of Sciences, bringing nearly 20 years of expertise in surgical robotics, computer-assisted medicine, and medical translation. He has led approximately 20 national and provincial scientific research projects and directed the development of vascular intervention surgical robot systems.

The founding team includes rehabilitation medicine professionals, experts from the State Key Laboratory of Robotics, former sales and product directors from medical device groups, and business professionals with extensive industry resources.

The company maintains close collaboration with clinical and research teams led by Academician Chen Lidian, President of the Chinese Rehabilitation Medicine Association and Director of the National-Local Joint Engineering Research Center for Rehabilitation Medical Technology.

Core Products

Wisebot X5 Upper Limb Rehabilitation Robot

The flagship Wisebot X5 represents a 3D upper limb mirror rehabilitation robot designed for stroke patients with hemiplegia. Built on neuroplasticity and mirror neuron rehabilitation theories, it features proprietary Brunnstrom staging and joint range-of-motion intelligent assessment technology, combined with deep learning-based intelligent rehabilitation training plan generation.

The system offers active, passive, active-passive, and mirror training modes. The mirror training mode enables patients to autonomously control affected-side movements, achieving coordinated bilateral synchronous training that enhances recovery outcomes.

Wisebot X3 Upper Limb Rehabilitation Robot

The Wisebot X3 provides 3D upper limb rehabilitation training with multiple assessment and training protocols suitable for patients across different recovery stages.

Wisebot X1 Hand Rehabilitation Robot

Designed for patients with hand movement disorders, the Wisebot X1 covers rehabilitation needs from flaccid paralysis through recovery stages with varied training modes.

Wisebot C1 Cognitive Rehabilitation System

The Wisebot C1 addresses cognitive assessment and training requirements, extending the company’s rehabilitation solutions beyond motor function.

Technology & Innovation

Huaquejing Medical has developed proprietary technologies across multiple domains:

• Unified software-hardware architecture for rehabilitation robots
• Robot control algorithms optimized for rehabilitation applications
• Human-machine interaction systems
• Intelligent assessment methodologies
• Exoskeleton biomimetic design
• Soft robotics integration
• Virtual reality applications
• Specialized sensor systems

The company’s intelligent rehabilitation products have received recognition including First Prize from the Chinese Rehabilitation Medicine Association, Second Prize for Science and Technology from the Chinese Acupuncture Society, First Prize for Science and Technology from the Guangdong Acupuncture Society, and Guangdong Famous High-Tech Product designation.

Market Presence

Huaquejing Medical serves multiple healthcare settings with differentiated product offerings:

• Hospital rehabilitation departments requiring professional-grade equipment
• Community rehabilitation centers needing accessible solutions
• Home rehabilitation applications for ongoing patient care

This multi-scenario approach enables full-cycle rehabilitation coverage.

Key Milestones

• 2019: Company founded in Shenzhen
• 2022: Achieved National High-Tech Enterprise certification; multiple products received NMPA registration certificates
• 2023: Completed Series A funding (tens of millions RMB) led exclusively by Shenzhen Capital Group

Frequently Asked Questions

What rehabilitation conditions do Huaquejing Medical products address?

The company’s products primarily target patients with upper limb motor dysfunction following stroke, as well as cognitive impairment. The Wisebot product line covers upper limb, hand function, and cognitive rehabilitation needs.

Has Huaquejing Medical received regulatory approval for its products?

Multiple products in the Wisebot series have obtained NMPA Class II medical device registration certificates in China.

Who are the investors in Huaquejing Medical?

The company completed its Series A funding round in January 2023 with exclusive investment from Shenzhen Capital Group (深创投), one of China’s largest venture capital firms.